Skip Navigation

Publication Detail

Title: Repeated gestational exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1) modulated effects in maternal and fetal tissues.

Authors: Cole, Toby B; Li, Wan-Fen; Co, Aila L; Hay, Ariel M; MacDonald, James W; Bammler, Theo K; Farin, Federico M; Costa, Lucio G; Furlong, Clement E

Published In Toxicol Sci, (2014 Oct)

Abstract: Chlorpyrifos oxon (CPO), the toxic metabolite of the organophosphorus (OP) insecticide chlorpyrifos, causes developmental neurotoxicity in humans and rodents. CPO is hydrolyzed by paraoxonase-1 (PON1), with protection determined by PON1 levels and the human Q192R polymorphism. To examine how the Q192R polymorphism influences fetal toxicity associated with gestational CPO exposure, we measured enzyme inhibition and fetal-brain gene expression in wild-type (PON1(+/+)), PON1-knockout (PON1(-/-)), and tgHuPON1R192 and tgHuPON1Q192 transgenic mice. Pregnant mice exposed dermally to 0, 0.50, 0.75, or 0.85 mg/kg/d CPO from gestational day (GD) 6 through 17 were sacrificed on GD18. Biomarkers of CPO exposure inhibited in maternal tissues included brain acetylcholinesterase (AChE), red blood cell acylpeptide hydrolase (APH), and plasma butyrylcholinesterase (BChE) and carboxylesterase (CES). Fetal plasma BChE was inhibited in PON1(-/-) and tgHuPON1Q192, but not PON1(+/+) or tgHuPON1R192 mice. Fetal brain AChE and plasma CES were inhibited in PON1(-/-) mice, but not in other genotypes. Weighted gene co-expression network analysis identified five gene modules based on clustering of the correlations among their fetal-brain expression values, allowing for correlation of module membership with the phenotypic data on enzyme inhibition. One module that correlated highly with maternal brain AChE activity had a large representation of homeobox genes. Gene set enrichment analysis revealed multiple gene sets affected by gestational CPO exposure in tgHuPON1Q192 but not tgHuPON1R192 mice, including gene sets involved in protein export, lipid metabolism, and neurotransmission. These data indicate that maternal PON1 status modulates the effects of repeated gestational CPO exposure on fetal-brain gene expression and on inhibition of both maternal and fetal biomarker enzymes.

PubMed ID: 25070982 Exiting the NIEHS site

MeSH Terms: Acetylcholinesterase/metabolism; Animals; Aryldialkylphosphatase/deficiency; Aryldialkylphosphatase/genetics; Aryldialkylphosphatase/metabolism*; Brain/drug effects*; Brain/enzymology; Butyrylcholinesterase/blood; Carboxylesterase/blood; Chlorpyrifos/analogs & derivatives*; Chlorpyrifos/toxicity; Erythrocytes/drug effects; Erythrocytes/enzymology; Female; GPI-Linked Proteins/metabolism; Gene Expression Profiling/methods; Gene Expression Regulation, Developmental/drug effects; Genome-Wide Association Study; Genotype; Gestational Age; Humans; Insecticides/toxicity*; Maternal Exposure; Mice, Knockout; Mice, Transgenic; Oligonucleotide Array Sequence Analysis; Peptide Hydrolases/blood; Phenotype; Polymorphism, Genetic; Pregnancy; RNA, Messenger/metabolism; Real-Time Polymerase Chain Reaction

Back
to Top